Paulo Neves

R&D

Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.

News

AstraZeneca and Daiichi Sankyo's Datroway enters the first-line triple-negative breast cancer market in the EU, taking on Gilead's Trodelvy.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.